Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 197.00
+3.00 (1.55%)
Sep 24, 2026, 2:59 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 15.87 billion as of September 25, 2026. Its market cap has increased by 620.03% in one year.
Market Cap
15.87B
Enterprise Value
15.05B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
197.00
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 15.87B, an increase of 608.61%. That is a compound annual growth rate of 116.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 15.87B | 296.38% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 22.36B |
| Sunmax Biotechnology | 21.51B |
| Oneness Biotech | 21.46B |
| Medigen Vaccine Biologics | 19.66B |
| TaiMed Biologics | 16.97B |
| Gongwin Biopharm Holdings | 16.59B |
| ACRO Biomedical | 16.34B |
| Ever Supreme Bio Technology | 16.07B |